18269-Ovarian Cancer-NA-1558

Ovarian Cancer

ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study ofTumor Treating Fields (TTFields, 200kHz) Concomitant with WeeklyPaclitaxel for the Treatment of Recurrent Ovarian Cancer

  • Details

ClinicalTrials.gov ID: NCT03940196
Diagnosis Type: NA
USOR Number:

  • Address

12123 SW 69th Avenue
Tigard, OR 97223
P: (971) 708-7600

Search by practice name, trial titles, indicators and specific disease types.